Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 320

1.

The american college of chest physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism.

Palareti G, Antonucci E, Mastroiacovo D, Ageno W, Pengo V, Poli D, Testa S, Tosetto A, Prandoni P.

J Thromb Haemost. 2018 Jul 30. doi: 10.1111/jth.14253. [Epub ahead of print]

PMID:
30059189
2.

Impact of Chronic Renal Failure on Ischemic and Bleeding Events at 1 Year in Patients With Acute Coronary Syndrome (from the Multicenter START ANTIPLATELET Registry).

Patti G, Ricottini E, Nenna A, Cavallari I, Antonucci E, Calabrò P, Cirillo P, Gresele P, Palareti G, Pengo V, Pignatelli P, Bisignani A, Marcucci R.

Am J Cardiol. 2018 Jun 27. pii: S0002-9149(18)31258-X. doi: 10.1016/j.amjcard.2018.05.049. [Epub ahead of print]

PMID:
30057232
3.

Cost-minimization analysis of venous thromboembolism diagnosis: Comparison of standalone imaging with a strategy incorporating D-dimer for exclusion of venous thromboembolism.

Verma K, Legnani C, Palareti G.

Res Pract Thromb Haemost. 2017 Jun 16;1(1):57-61. doi: 10.1002/rth2.12008. eCollection 2017 Jul.

4.

Gender-Related Differences in Antiplatelet Therapy and Impact on 1-Year Clinical Outcome in Patients Presenting With ACS: The START ANTIPLATELET Registry.

Cirillo P, Di Serafino L, Patti G, Antonucci E, Calabrò P, Gresele P, Palareti G, Pengo V, Pignatelli P, Marcucci R.

Angiology. 2018 Jan 1:3319718783866. doi: 10.1177/0003319718783866. [Epub ahead of print]

PMID:
29969919
5.

Mechanical prosthetic heart valves: Quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study.

Poli D, Antonucci E, Pengo V, Migliaccio L, Testa S, Lodigiani C, Coffetti N, Facchinetti R, Serricchio G, Falco P, Mangione C, Masottini S, Ruocco L, De Caterina R, Palareti G; Italian Federation of Anticoagulation Clinics.

Int J Cardiol. 2018 Sep 15;267:68-73. doi: 10.1016/j.ijcard.2018.04.042.

PMID:
29957264
6.

Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Event registry.

Testa S, Ageno W, Antonucci E, Morandini R, Beyer-Westendorf J, Paciaroni M, Righini M, Sivera P, Verhamme P, Pengo V, Poli D, Palareti G.

Intern Emerg Med. 2018 May 22. doi: 10.1007/s11739-018-1877-z. [Epub ahead of print]

PMID:
29790125
7.

The vexed question of whether or not to measure levels of direct oral anticoagulants before surgery or invasive procedures.

Tripodi A, Marongiu F, Moia M, Palareti G, Pengo V, Poli D, Prisco D, Testa S, Zanazzi M.

Intern Emerg Med. 2018 Apr 26. doi: 10.1007/s11739-018-1854-6. [Epub ahead of print] Review.

PMID:
29700696
8.

Epidemiology and Management of Patients With Acute Coronary Syndromes in Contemporary Real-World Practice: Evolving Trends From the EYESHOT Study to the START-ANTIPLATELET Registry.

Calabrò P, Gragnano F, di Maio M, Patti G, Antonucci E, Cirillo P, Gresele P, Palareti G, Pengo V, Pignatelli P, Pennacchi M, Granatelli A, De Servi S, De Luca L, Marcucci R; for EYESHOT Study and Start Antiplatelet Register.

Angiology. 2018 Jan 1:3319718760917. doi: 10.1177/0003319718760917. [Epub ahead of print]

PMID:
29544348
9.

Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants.

Testa S, Paoletti O, Legnani C, Dellanoce C, Antonucci E, Cosmi B, Pengo V, Poli D, Morandini R, Testa R, Tripodi A, Palareti G.

J Thromb Haemost. 2018 May;16(5):842-848. doi: 10.1111/jth.14001. Epub 2018 Apr 17.

PMID:
29532628
10.

Comparison of five specific assays for determination of dabigatran plasma concentrations in patients enrolled in the START-Laboratory Register.

Cini M, Legnani C, Cosmi B, Testa S, Dellanoce C, Paoletti O, Marcucci R, Poli D, Paniccia R, Pengo V, Tripodi A, Palareti G; START-Laboratory Register.

Int J Lab Hematol. 2018 Apr;40(2):229-236. doi: 10.1111/ijlh.12772. Epub 2018 Jan 3.

PMID:
29314632
11.

Warfarin prescription in patients with nonvalvular atrial fibrillation and one non-gender-related risk factor (CHA2 DS2 VASc 1 or 2): A treatment dilemma.

Denas G, Zoppellaro G, Padayattil Jose S, Antonucci E, Marongiu F, Poli D, Testa S, Tripodi A, Palareti G, Pengo V.

Cardiovasc Ther. 2018 Feb;36(1). doi: 10.1111/1755-5922.12310. Epub 2017 Nov 11.

PMID:
29078033
12.

Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome.

Patti G, Cavallari I, Antonucci E, Calabrò P, Cirillo P, Gresele P, Palareti G, Pengo V, Pignatelli P, Ricottini E, Marcucci R.

PLoS One. 2017 Oct 23;12(10):e0186961. doi: 10.1371/journal.pone.0186961. eCollection 2017.

13.

Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis.

Khan F, Rahman A, Carrier M, Kearon C, Schulman S, Couturaud F, Prandoni P, Eichinger S, Becattini C, Agnelli G, Büller HR, Brighton TA, Palareti G, Pinede L, Sabri E, Hutton B, Wells GA, Rodger MA; MARVELOUS Collaborators.

BMJ Open. 2017 Sep 21;7(9):16950. doi: 10.1136/bmjopen-2017-016950. Review.

14.

Optimal long-term pharmacological treatment of patients with venous thromboembolism that was unprovoked or associated with weak risk factors.

Palareti G.

Expert Rev Hematol. 2017 Oct;10(10):921-931. doi: 10.1080/17474086.2017.1366851. Epub 2017 Aug 21. Review.

PMID:
28803491
15.

External validation of the DASH prediction rule: a retrospective cohort study.

Tosetto A, Testa S, Martinelli I, Poli D, Cosmi B, Lodigiani C, Ageno W, De Stefano V, Falanga A, Nichele I, Paoletti O, Bucciarelli P, Antonucci E, Legnani C, Banfi E, Dentali F, Bartolomei F, Barcella L, Palareti G.

J Thromb Haemost. 2017 Oct;15(10):1963-1970. doi: 10.1111/jth.13781. Epub 2017 Aug 23.

PMID:
28762665
16.

ANMCO Position Paper: long-term follow-up of patients with pulmonary thromboembolism.

D'Agostino C, Zonzin P, Enea I, Gulizia MM, Ageno W, Agostoni P, Azzarito M, Becattini C, Bongarzoni A, Bux F, Casazza F, Corrieri N, D'Alto M, D'Amato N, D'Armini AM, De Natale MG, Di Minno G, Favretto G, Filippi L, Grazioli V, Palareti G, Pesavento R, Roncon L, Scelsi L, Tufano A.

Eur Heart J Suppl. 2017 May;19(Suppl D):D309-D332. doi: 10.1093/eurheartj/sux030. Epub 2017 May 2.

17.

Endothelial activation in patients with superficial vein thrombosis (SVT) of the lower limbs.

Falcinelli E, Cosmi B, Filippini M, Petito E, Legnani C, Cini M, Guglielmini G, Migliacci R, Palareti G, Gresele P.

Thromb Res. 2017 Sep;157:20-22. doi: 10.1016/j.thromres.2017.06.033. Epub 2017 Jun 27. No abstract available.

PMID:
28679113
18.

Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism.

Pesavento R, Filippi L, Palla A, Visonà A, Bova C, Marzolo M, Porro F, Villalta S, Ciammaichella M, Bucherini E, Nante G, Battistelli S, Muiesan ML, Beltramello G, Prisco D, Casazza F, Ageno W, Palareti G, Quintavalla R, Monti S, Mumoli N, Zanatta N, Cappelli R, Cattaneo M, Moretti V, Corà F, Bazzan M, Ghirarduzzi A, Frigo AC, Miniati M, Prandoni P; SCOPE Investigators.

Eur Respir J. 2017 May 25;49(5). pii: 1601980. doi: 10.1183/13993003.01980-2016. Print 2017 May.

PMID:
28546279
19.

Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago.

Palareti G, Antonucci E, Migliaccio L, Erba N, Marongiu F, Pengo V, Poli D, Testa S, Tosetto A, Tripodi A, Moia M; centers participating in the FCSA-START-Register (The ISCOAT 2016 study: Italian Study on Complications of Oral Anticoagulant Therapy-2016).

Intern Emerg Med. 2017 Dec;12(8):1109-1119. doi: 10.1007/s11739-017-1678-9. Epub 2017 May 13.

20.

Residual vein thrombosis and serial D-dimer for the long-term management of patients with deep venous thrombosis.

Prandoni P, Vedovetto V, Ciammaichella M, Bucherini E, Corradini S, Enea I, Cosmi B, Mumoli N, Visonà A, Barillari G, Bova C, Quintavalla R, Zanatta N, Pedrini S, Villalta S, Camporese G, Testa S, Parisi R, Becattini C, Cuppini S, Pengo V, Palareti G; Morgagni Investigators.

Thromb Res. 2017 Jun;154:35-41. doi: 10.1016/j.thromres.2017.04.002. Epub 2017 Apr 4.

PMID:
28407492
21.

Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European society of cardiology working groups of aorta and peripheral circulation and pulmonary circulation and right ventricular function.

Mazzolai L, Aboyans V, Ageno W, Agnelli G, Alatri A, Bauersachs R, Brekelmans MP, Büller HR, Elias A, Farge D, Konstantinides S, Palareti G, Prandoni P, Righini M, Torbicki A, Vlachopoulos C, Brodmann M.

Eur Heart J. 2017 Feb 17. doi: 10.1093/eurheartj/ehx003. [Epub ahead of print] No abstract available.

PMID:
28329262
22.

Comparison of HAS-BLED and HAS-BED Versus CHADS2 and CHA2DS2VASC Stroke and Bleeding Scores in Patients With Atrial Fibrillation.

Poli D, Antonucci E, Pengo V, Testa S, Palareti G.

Am J Cardiol. 2017 Apr 1;119(7):1012-1016. doi: 10.1016/j.amjcard.2016.12.007. Epub 2017 Jan 26.

PMID:
28237286
23.

Italian intersociety consensus on DOAC use in internal medicine.

Prisco D, Ageno W, Becattini C, D'Angelo A, Davì G, De Cristofaro R, Dentali F, Di Minno G, Falanga A, Gussoni G, Masotti L, Palareti G, Pignatelli P, Santi RM, Santilli F, Silingardi M, Tufano A, Violi F; SIMI (Italian Society of Internal Medicine); FADOI (Federation of Associations of Hospital Doctors on Internal Medicine); SISET (Italian Society for the Study of Haemostasis and Thrombosis).

Intern Emerg Med. 2017 Apr;12(3):387-406. doi: 10.1007/s11739-017-1628-6. Epub 2017 Feb 13.

PMID:
28191610
24.

Do isolated calf deep vein thrombosis need anticoagulant treatment?

Palareti G.

J Thorac Dis. 2016 Dec;8(12):E1691-E1693. doi: 10.21037/jtd.2016.12.93. No abstract available.

25.

Intracranial hemorrhage recurrence on vitamin K antagonist: severity of the first episode and HASBLED score fail to identify high-risk patients from the CHIRONE study.

Poli D, Antonucci E, Dentali F, Testa S, Palareti G; on the behalf of the Italian Federation of Anticoagulation Clinics (FCSA).

Blood Coagul Fibrinolysis. 2017 Jan;28(1):62-65. doi: 10.1097/MBC.0000000000000540.

PMID:
28081031
26.

[ANMCO Position paper: Recommendations for the follow-up of patients with pulmonary thromboembolism].

D'Agostino C, Zonzin P, Enea I, Gulizia MM, Ageno W, Agostoni P, Azzarito M, Becattini C, Bongarzoni A, Bux F, Casazza F, Corrieri N, D'Alto M, D'Amato N, D'Armini AM, De Natale MG, Di Minno G, Favretto G, Filippi L, Grazioli V, Palareti G, Pesavento R, Roncon L, Scelsi L, Tufano A.

G Ital Cardiol (Rome). 2016 Sep;17(9 Suppl 1):68S-109. doi: 10.1714/2450.25670. Italian.

PMID:
27869893
27.

Ultrasound Characteristics of Calf Deep Vein Thrombosis and Residual Vein Obstruction After Low Molecular Weight Heparin Treatment.

Sartori M, Lessiani G, Favaretto E, Migliaccio L, Iotti M, Giusto L, Ghirarduzzi A, Palareti G, Cosmi B.

Eur J Vasc Endovasc Surg. 2016 Nov;52(5):658-664. doi: 10.1016/j.ejvs.2016.07.022. Epub 2016 Sep 7.

28.

Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study.

Testa S, Legnani C, Tripodi A, Paoletti O, Pengo V, Abbate R, Bassi L, Carraro P, Cini M, Paniccia R, Poli D, Palareti G.

J Thromb Haemost. 2016 Nov;14(11):2194-2201. doi: 10.1111/jth.13486. Epub 2016 Oct 15.

PMID:
27566988
29.

Validation of STA-Liatest D-Di assay for exclusion of pulmonary embolism according to the latest Clinical and Laboratory Standard Institute/Food and Drug Administration guideline. Results of a multicenter management study.

Pernod G, Wu H, de Maistre E, Lazarchick J, Kassis J, Aguilar C, Vera PM, Palareti G, D'Angelo A; DiET Study Group (Jeffrey Caterino, Fabienne Dutrillaux, Gary Headden, Colin Kaide, Maxime Maignan, Raphaël Marlu, Anais Richard, Cindy Tissier).

Blood Coagul Fibrinolysis. 2017 Apr;28(3):254-260. doi: 10.1097/MBC.0000000000000591.

30.

Treatment of Isolated Below the Knee Deep Vein Thrombosis.

Palareti G, Sartori M.

Curr Atheroscler Rep. 2016 Jul;18(7):37. doi: 10.1007/s11883-016-0594-1. Review.

PMID:
27221499
31.

The ICMJE editors' proposal on sharing individual data collected in clinical trials: Comments.

Palareti G.

Eur J Intern Med. 2016 Jul;32:e9. doi: 10.1016/j.ejim.2016.04.025. Epub 2016 May 13. No abstract available.

PMID:
27184116
32.

OC-15 - Risk factors for cancer development after idiopathic venous thromboembolism.

Cosmi B, Legnani C, Ghirarduzzi A, De Micheli V, Pengo V, Testa S, Poli D, Antonucci E, Prisco D, Tripodi A, Prandoni P, Palareti G; FCSA, Italian Federation of Anticoagulation Clinics.

Thromb Res. 2016 Apr;140 Suppl 1:S174. doi: 10.1016/S0049-3848(16)30132-3. Epub 2016 Apr 8.

PMID:
27161686
33.

Duration of anticoagulation after isolated pulmonary embolism.

Palareti G, Cosmi B, Antonucci E, Legnani C, Erba N, Ghirarduzzi A, Poli D, Testa S, Tosetto A, Pengo V, Prandoni P; DULCIS investigators.

Eur Respir J. 2016 May;47(5):1429-35. doi: 10.1183/13993003.01126-2015. Epub 2016 Feb 25.

34.

The incidence of heparin-induced thrombocytopenia in patients treated with low molecular weight heparin for superficial vein thrombosis.

Sartori M, Favaretto E, Migliaccio L, Guazzaloca G, Legnani C, Palareti G, Cosmi B.

Thromb Res. 2016 Mar;139:154-7. doi: 10.1016/j.thromres.2016.02.004. Epub 2016 Feb 3.

PMID:
26916314
35.

The SAME-TT2R2 score predicts the quality of anticoagulation control in patients with acute VTE. A real-life inception cohort study.

Palareti G, Antonucci E, Lip GY, Testa S, Guazzaloca G, Falanga A, Pengo V, Poli D; START-Register Participants.

Thromb Haemost. 2016 Jun 2;115(6):1101-8. doi: 10.1160/TH15-10-0830. Epub 2016 Jan 28.

PMID:
26819229
36.

Plasma levels of direct oral anticoagulants in real life patients with atrial fibrillation: Results observed in four anticoagulation clinics.

Testa S, Tripodi A, Legnani C, Pengo V, Abbate R, Dellanoce C, Carraro P, Salomone L, Paniccia R, Paoletti O, Poli D, Palareti G; START-Laboratory Register.

Thromb Res. 2016 Jan;137:178-83. doi: 10.1016/j.thromres.2015.12.001. Epub 2015 Dec 2.

PMID:
26672898
37.

The challenges and limitations of widespread direct oral anticoagulant treatment: practical suggestions for their best use.

Palareti G, Poli D.

Expert Rev Cardiovasc Ther. 2016;14(2):163-76. doi: 10.1586/14779072.2016.1115344. Epub 2015 Dec 14. Review.

PMID:
26652975
38.

Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Andreozzi GM, Bignamini AA, Davì G, Palareti G, Matuška J, Holý M, Pawlaczyk-Gabriel K, Džupina A, Sokurenko GY, Didenko YP, Andrei LD, Lessiani G, Visonà A; SURVET Study Investigators.

Circulation. 2015 Nov 17;132(20):1891-7. doi: 10.1161/CIRCULATIONAHA.115.016930. Epub 2015 Sep 25.

39.

The risk of a first and a recurrent venous thrombosis associated with an elevated D-dimer level and an elevated thrombin potential: results of the THE-VTE study: comment.

Tripodi A, Legnani C, Palareti G.

J Thromb Haemost. 2015 Dec;13(12):2283-6. doi: 10.1111/jth.13151. Epub 2015 Oct 29. No abstract available.

40.

Comparison between different D-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS study.

Palareti G, Legnani C, Cosmi B, Antonucci E, Erba N, Poli D, Testa S, Tosetto A; DULCIS (D-dimer-ULtrasonography in Combination Italian Study) Investigators (See Appendix); DULCIS (D-dimer-ULtrasonography in Combination Italian Study) Investigators.

Int J Lab Hematol. 2016 Feb;38(1):42-9. doi: 10.1111/ijlh.12426. Epub 2015 Sep 12.

PMID:
26362346
41.

The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation.

Antonucci E, Poli D, Tosetto A, Pengo V, Tripodi A, Magrini N, Marongiu F, Palareti G; START-Register.

PLoS One. 2015 May 22;10(5):e0124719. doi: 10.1371/journal.pone.0124719. eCollection 2015.

42.

D-Dimer Testing in Patients With a First Unprovoked Venous Thromboembolism.

Palareti G.

Ann Intern Med. 2015 May 5;162(9):670-1. doi: 10.7326/L15-5089. No abstract available.

PMID:
25939005
43.

D-dimer for the diagnosis of upper extremity deep and superficial venous thrombosis.

Sartori M, Migliaccio L, Favaretto E, Cini M, Legnani C, Palareti G, Cosmi B.

Thromb Res. 2015 Apr;135(4):673-8. doi: 10.1016/j.thromres.2015.02.007. Epub 2015 Feb 14.

PMID:
25700619
44.

Diagnosis of deep vein thrombosis, and prevention of deep vein thrombosis recurrence and the post-thrombotic syndrome in the primary care medicine setting anno 2014.

Michiels JJ, Michiels JM, Moossdorff W, Lao M, Maasland H, Palareti G.

World J Crit Care Med. 2015 Feb 4;4(1):29-39. doi: 10.5492/wjccm.v4.i1.29. eCollection 2015 Feb 4. Review.

45.

Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data.

Marcucci M, Iorio A, Douketis JD, Eichinger S, Tosetto A, Baglin T, Cushman M, Palareti G, Poli D, Tait RC, Kyrle PA.

J Thromb Haemost. 2015 May;13(5):775-81. doi: 10.1111/jth.12871. Epub 2015 Mar 12.

46.

How D-dimer assay can be useful in deciding the duration of anticoagulation after venous thromboembolism: a review.

Palareti G.

Expert Rev Hematol. 2015 Feb;8(1):79-88. doi: 10.1586/17474086.2015.975791. Epub 2014 Oct 28. Review.

PMID:
25348806
47.

Clinical decision rules and D-Dimer in venous thromboembolism: current controversies and future research priorities.

Rodger MA, Le Gal G, Wells P, Baglin T, Aujesky D, Righini M, Palareti G, Huisman M, Meyer G.

Thromb Res. 2014 Oct;134(4):763-8. doi: 10.1016/j.thromres.2014.07.031. Epub 2014 Aug 4. Review.

PMID:
25129416
48.

D-dimer, FVIII and thrombotic burden in the acute phase of deep vein thrombosis in relation to the risk of post-thrombotic syndrome.

Sartori M, Favaretto E, Cini M, Legnani C, Palareti G, Cosmi B.

Thromb Res. 2014 Aug;134(2):320-5. doi: 10.1016/j.thromres.2014.05.043. Epub 2014 Jun 8.

PMID:
24968959
49.

D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study.

Palareti G, Cosmi B, Legnani C, Antonucci E, De Micheli V, Ghirarduzzi A, Poli D, Testa S, Tosetto A, Pengo V, Prandoni P; DULCIS (D-dimer and ULtrasonography in Combination Italian Study) Investigators.

Blood. 2014 Jul 10;124(2):196-203. doi: 10.1182/blood-2014-01-548065. Epub 2014 May 30.

50.

Direct oral anticoagulants and bleeding risk (in comparison to vitamin K antagonists and heparins), and the treatment of bleeding.

Palareti G.

Semin Hematol. 2014 Apr;51(2):102-11. doi: 10.1053/j.seminhematol.2014.02.002. Epub 2014 Feb 28. Review.

PMID:
24861794

Supplemental Content

Loading ...
Support Center